Two related but differentially expressed potential membrane proteins of Epstein-Barr virus are encoded by the same reading frame in the EcoRI D het region of the viral genome. Potential antigenic sites in the amino acid sequence of these proteins were selected by computer-aided prediction of the secondary structure and two oligopeptides corresponding to regions located in different parts of the proteins were synthesized chemically. Rabbit antisera to these peptides were used for immunoprecipitation of the native viral proteins from Epstein-Barr virus-positive cell lines from various sources. Both predicted membrane proteins could be precipitated from cell lines that had been transformed in vitro with EBV or from cell lines derived from infectious mononucleosis patients. In cell lines established from Burkitt lymphoma, only the smaller polypeptide, which lacks 138 amino acids from the amino terminus, could be identified. Using the synthetic peptides as antigens in ELISA, we detected elevated antibody titers in sera from patients with infectious mononucleosis and nasopharyngeal carcinoma.
Epstein-Barr virus (EBV), a human herpesvirus, causes infectious mononucleosis (1, 2) as a primary disease and remains latent in human B lymphocytes, transforming them into lymphoblastoid cells that proliferate indefinitely upon cultivation in vitro (3, 4) . EBV has also been found to be associated with African Burkitt lymphoma (5) (6) (7) and nasopharyngeal carcinoma (8, 9) and with polyclonal lymphomas in immunosuppressed individuals (10) .
At least five regions of the viral genome are transcribed during latency: the small unique (Us) region is transcribed to give EBER RNAs (11) ; the internal repeat region with neighboring sequences encodes the nuclear antigen EBNA2 (12) ; the BamHI fragment-K region encodes EBNA1 (13, 14) ; a region in the long unique (UL) region codes for EBNA3 (15) ; and the region of the EcoRI D het fragment at the right end of the viral DNA codes for a potential membrane protein (16) (17) (18) . Two related membrane proteins were proposed to be expressed from this reading frame, BNLF1 (19) , which has promoters with differential activity and a single 3'-terminal end. The shorter of the two proteins would lack 138 amino acids from the amino terminus (ref. 20 ; Fig. 1 ). Further, it was predicted that the larger protein would have a highly charged amino terminus followed by a hydrophobic domain, consisting of six transmembrane regions, and a large hydrophilic carboxyl-terminal region. The existence of an EBV-associated membrane protein in latently infected cells was also suggested by studies of cytotoxic T-cell clones (21) (22) (23) (24) , which recognize an antigen, found only on EBV-infected cells, known as lymphocyte-determined membrane antigen (LYDMA). The biochemical properties ofthis antigen are not known.
For further characterization of the EBV-encoded membrane antigen in latently infected cells ("latent membrane antigen" or BNLF1-MA), we synthesized oligopeptides corresponding to the amino-terminal part and to the repeat unit that is part of the large hydrophilic carboxyl-terminal domain. (The first one should only be present in the larger protein, whereas the latter is a part ofboth proteins.) Antisera against the peptides were used for immunoprecipitation ofthe native proteins from various cell lines.
The peptides were also used as antigens in ELISA assays, in which sera from patients suffering from infectious mononucleosis and the EBV-related nasopharyngeal carcinoma were tested for the presence of the respective antibodies.
MATERIALS AND METHODS
Computer-Predicted Analysis of the Secondary Structure. The secondary structure of the latent membrane protein was predicted by a program, written for a VAX 750 computer, based on suggestions by Cohen et al. (25) , using the algorithms of Chou and Fasman (26) or Garnier et al. (27) to predict secondary structures. These predictions were superimposed with the values oflocal hydrophilicity determined by the method of Hopp and Woods (28) . As alternatives, values for surface probability [modified from Emini et al. (29) ] or flexibility (30) can be superimposed. The probability of the occurrence of a-helices, A-pleated sheets, random coils, and 1-turn regions was evaluated using stringent conditions (31) .
The parameters for hydrophilicity were averaged over five amino acid residues, with a limit of 0.7. a-Helical structures in a hydrophilic or nonhydrophobic environment are likely candidates for antigenic sites, since they frequently form loop-like structures at the protein surface.
Peptide Synthesis. Two peptides were synthesized (for sequence and location, see Fig. 1C ) using the Merrifield solid-phase methods (32) with the following modifications. Before and after deprotection of N-t-butoxycarbonyl (N-tBoc) amino acids, a series of three washes, with methylene chloride, absolute ethanol, and methylene chloride, respectively, was used; deprotection of N-t-Boc amino acids was done with 25% trifluoroacetic acid in methylene chloride. Completeness of deprotection and coupling reactions were monitored by the ninhydrin color test (33) . All coupling reactions were carried out using a 4-fold excess of N-t-Boc amino acids and a 3-fold excess of dicyclohexylcarbodiimide (Aldrich) according to the amount of the first amino acid. All N-t-Boc amino acids were purchased from Sigma; N-tbutoxycarbonyl-4-methoxybenzylcysteine-0-resin was purchased from Peninsula Laboratories (St. Helens, England).
Abbreviations: EBV, Epstein-Barr virus; EBNA, EBV-encoded nuclear antigen; KLH, keyhole limpet hemocyanin.
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The side chains were cleaved from the resin in thioanisole suspension at 0C with anhydrous hydrogen fluoride (Matheson). After precipitation and extensive washing with ethyl acetate, the peptide was lyophilized, extracted with 1.5% NH4HCO3, and purified by molecular sieving (Bio-Gel P-4 column, Bio-Rad).
Immunization of Rabbits. For the production of antisera, two alternative procedures were used. (i) The peptides were coupled to keyhole limpet hemocyanin (KLH) (34) with m-maleimidobenzoyl-N-hydroxysuccinimide ester. Since this coupling reaction requires the presence of a thiol group, cysteine was included as the first amino acid at the carboxyl terminus. (it) The amino acids glycine, glycine, and lysine (Lys-Gly-Gly) were covalently linked to the amino terminus of the peptide, and both amino groups of the terminal lysine were esterified with palmitic acid by following the procedure of solid-phase synthesis (35) .
Rabbits were inoculated subcutaneously with a 1-ml emulsion of antigen (200 ug of the palmitoylated peptides or 400 Ag ofthe KLH conjugate) in phosphate-buffered saline (PBS: 130 mM NaCl/2.7 mM KCl/8 mM Na2HPO4/1.5 mM KH2PO4/0.9 mM CaCl2/0. 5 (20) , we synthesized peptides corresponding to the sequence of the hydrophilic P-turn region from the amino terminus of the large protein (peptide [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] and to the sequence of a hydrophilic repeat unit (peptide 252-263) that is located downstream from the transmembrane region and should be a common antigenic epitope of both forms of the membrane proteins. The sequences of the peptides are indicated in Fig. 1C .
Antisera against the peptides were raised in rabbits immunized with dipalmitoyllysylglyrylglycyl or with KLH-peptide conjugate. When tested in ELISA assays, the sera showed titers up to 1:200,000 against the individual peptides.
Screening of Human Sera for Peptide Antibodies. To identify antibodies against oligopeptides derived from the latent membrane antigens, peptides [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] (Fig. 2) Raji (37) , Jijoye (38) , Namalwa (39) , and P3HR1 (40); from the in vitro-transformed marmoset cell line B95-8 (41) , from the in vitro-transformed human cord-blood lines CB176-HK975 (provided by G. Lenoir, International Agency for Research on Cancer, Lyon, France) and J-Aba (42); and from two spontaneous cell lines derived from infectious mononucleosis patients (RB and RS). BJAB (43) and Ramos (44) were used as EBV-negative lines. Antiserum against the aminoterminal peptide 1-18 specifically immunoprecipitated proteins of 60-70 kDa from lysates of in vitro-transformed and spontaneous cell lines (Fig. 3A) . The variation in molecular mass is likely due to variations in the number of repeat units present in the viral genome of the various cell lines (17) . No protein that reacted specifically with the antiserum to peptide 1-18 was found in any of the Burkitt lymphoma lines. The result was similar for EBV-negative cell lines. When the serum directed against peptide 252-263 from the amino acid repeat at the carboxyl-terminal part of the predicted sequence was used for immunoprecipitation (Fig.  3B ), a protein with the same molecular mass range as described above (60-70 kDa) was identified in the in vitrotransformed lines B95-8, CB176HK975, and (data not shown) J-Aba and in the infectious mononucleosis lines RB and (data not shown) RS, together with a second protein of apparent molecular mass ranging from 50 to 60 kDa. Polypeptides of 50. 60 kDa were also detected in the Burkitt lymphoma cells Raji, Jijoye, and Namalwa; in P3HR1 we found only a very weak reaction. No protein was identified in the EBV-negative cell lines (Fig. 3 A and B) .
The apparent sizes of the proteins in NaDodSO4/ polyacrylamide gels, 60-70 kDa and 50-60 kDa, were different from the predicted values (42 kDa and 28 kDa, respectively). This anomalous behavior of the polypeptides may be due to the high content of aspartic acid and proline and was also reported by other groups (17, 18) . Identification of these polypeptides was clearer when [14C]leucine was used for labeling, which is compatible with the presence of only 3 methionine but 34 leucine residues in the sequence.
When cells were treated with phorbol 12-myristate 13-acetate and butyric acid to induce the synthesis of late viral gene products, no polypeptides were identified by immunoprecipitation with the anti-peptide sera (Fig. 3C) . A similar result was obtained when protein synthesis was blocked by cycloheximide, followed by a labeling period when further RNA synthesis was inhibited by the addition of actinomycin D. When viral DNA synthesis was inhibited by phosphonoacetic acid, the latent membrane proteins were detected in the treated cells. We conclude that the identified proteins belong to a group of viral gene products whose synthesis is blocked by viral DNA synthesis.
DISCUSSION
This work presents data for a differential expression of protein products ofthe open reading frame BNLF1 (19) in the EcoRI fragment-D region of EBV. This reading frame has been shown to code for two viral transcripts (20) , the larger of which has been reported to be a latent membrane protein (17, 18) , which may be the still-unidentified target antigen of cytotoxic T cells directed against EBV-infected cells. Taking into account computer-predicted analysis of secondary structures and hydrophilicity of amino acids, we synthesized antigenic epitopes from various regions of the protein.
Antibodies prepared against the peptides were able to identify the original viral products. It Another possibility is that this protein alone is not sufficient to elicit cytotoxic-T-cell reaction. The highly charged amino terminus and the following hydrophobic transmembrane part may be involved in complex formations and conformational changes with other components of the cell membrane, which then may be the target for the T-cell recognition.
